Recommended voluntary exchange offer to the shareholders of Topdanmark A/S – DKK 33 billion FIG Recommended voluntary exchange offer to the shareholders of Topdanmark A/S – DKK 33 billion
Public cash offer to ChromoGenics AB (SE) Cleantech, Renewables & Infrastructure Public cash offer to ChromoGenics AB (SE)
Recommended public cash offer to shareholders in Resurs Holding AB — SEK 4,700 million FIG Recommended public cash offer to shareholders in Resurs Holding AB — SEK 4,700 million
Strategic partnership with Shandong Innovation Group by Gränges Business Services Strategic partnership with Shandong Innovation Group by Gränges
Capital raise for Coop Danmark A/S - DKK 2 billion Consumer & Retail Capital raise for Coop Danmark A/S - DKK 2 billion
Public offer to the shareholders of OX2 AB (SE) — SEK 16 billion Cleantech, Renewables & Infrastructure Public offer to the shareholders of OX2 AB (SE) — SEK 16 billion
Rights issue in Lifecare ASA (NO) — NOK 90 million Healthcare Rights issue in Lifecare ASA (NO) — NOK 90 million
Rights issue in Lipidor AB (SE) — SEK 38 million Healthcare Rights issue in Lipidor AB (SE) — SEK 38 million
Initial public offering of Cinlus Pharma AB (SE) on Nasdaq Stockholm – SEK 715 million Healthcare Initial public offering of Cinlus Pharma AB (SE) on Nasdaq Stockholm – SEK 715 million
Public share offering in Faron — EUR 30.7 million Healthcare Public share offering in Faron — EUR 30.7 million